• / Free eNewsletters & Magazine
  • / My Account
Home>Insider Trading

Insider Trading

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Supreme Court Turns Away Gupta Appeal

    Supreme Court Turns Away Gupta Appeal

  2. Court Denies Request to Reconsider Insider Trading Decision

    Court Denies Request to Reconsider Insider Trading Decision

  3. SEC charges two with insider trading on proposed Cooper Tires deal

    SEC charges two with insider trading on proposed Cooper Tires deal

  4. Court will not reconsider key ruling on insider trading

    Court will not reconsider key ruling on insider trading

  5. French Prosecutors Dismiss Insider Trading Complaints Against BNP Paribas Executives

    French Prosecutors Dismiss Insider Trading Complaints Against BNP Paribas Executives

  6. Allergan, Valeant, Pershing Square settle lawsuit

    Allergan, Valeant, Pershing Square settle lawsuit

  7. WeissLaw LLP: The Cellular Dynamics International Acquisition by FUJIFILM Holdings Corporation Is the Subject of a Legal Investigation

    WeissLaw LLP: The Cellular Dynamics International Acquisition by FUJIFILM Holdings Corporation Is the Subject of a Legal Investigation

  8. WeissLaw LLP: The Auspex Pharmaceuticals, Inc. Acquisition by Teva Pharmaceutical Industries Is the Subject of a Legal Investigation

    WeissLaw LLP: The Auspex Pharmaceuticals, Inc. Acquisition by Teva Pharmaceutical Industries Is the Subject of a Legal Investigation

  9. WeissLaw LLP: The Hyperion Therapeutics, Inc. Acquisition by Horizon Pharma Plc Is the Subject of a Legal Investigation

    WeissLaw LLP: The Hyperion Therapeutics, Inc. Acquisition by Horizon Pharma Plc Is the Subject of a Legal Investigation

  10. WeissLaw LLP: Hyperion Therapeutics, Inc. Acquisition By Horizon Pharma Plc May Not Be In The Best Interest of HPTX Shareholders

    WeissLaw LLP: Hyperion Therapeutics, Inc. Acquisition By Horizon Pharma Plc May Not Be In The Best Interest of HPTX Shareholders

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.